Return on Invested Capital (ROIC): 8.43%
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of 8.43% is 16% below its 5-year average of 10.04%, near the low end of its 5-year range (6.96%–15.26%).
As of Friday, June 26, 2026. 9.55% above its 12-month average of 7.70%.
DGX Return on Invested Capital (ROIC) Chart
Annual fiscal-year return on invested capital; no daily interpolation.
DGX Average Return on Invested Capital (ROIC) Chart
DGX Current vs Average Return on Invested Capital (ROIC) Chart
DGX Return on Invested Capital (ROIC) Metrics
RETURN ON INVESTED CAPITAL (ROIC)
8.43%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
7.70%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
8.24%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
10.04%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
9.57%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
9.09%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
9.69%
CURRENT VS TTM AVG
+9.55%
CURRENT VS 3Y AVG
+2.27%
CURRENT VS 5Y AVG
-16.05%
CURRENT VS 10Y AVG
-11.93%
CURRENT VS 15Y AVG
-7.25%
CURRENT VS 20Y AVG
-13.00%
DGX Competitors' Return on Invested Capital (ROIC)
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Quest Diagnostics Incorporated (DGX) | $22.83B | 8.43% | 7.70% | 8.24% | 10.04% |
| BioNTech SE (BNTX)vs › | $22.76B | -3.14% | -4.79% | 9.55% | 20.42% |
| United Therapeutics Corporation (UTHR)vs › | $23.07B | 16.14% | 15.79% | 14.57% | 13.09% |
| Moderna, Inc. (MRNA)vs › | $23.71B | -29.70% | -31.12% | -12.69% | 0.19% |
| Labcorp Holdings Inc. (LH)vs › | $21.83B | 7.39% | 6.30% | 5.64% | 7.56% |
| Incyte Corporation (INCY)vs › | $21.48B | 20.58% | 10.42% | 9.36% | 7.13% |
| Waters Corporation (WAT)vs › | $24.57B | 17.57% | 18.00% | 20.73% | 22.79% |
| Mettler-Toledo International Inc. (MTD)vs › | $25.13B | 35.46% | 38.26% | 37.51% | 36.01% |
| STERIS plc (STE)vs › | $20.52B | 8.47% | 7.82% | 7.13% | 6.49% |
| Veeva Systems Inc. (VEEV)vs › | $25.68B | 9.48% | 9.25% | 9.54% | 11.31% |
Capital Efficiency
ROIC
8.4%
ROE
13.9%
Return on Invested Capital (ROIC) Formula & Definition
ROIC = NOPAT / Invested Capital
Return on invested capital measures the after-tax return a company earns on all capital (debt and equity) invested in the business.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Return on Invested Capital (ROIC) FAQ
- What is the return on invested capital (ROIC) for Quest Diagnostics Incorporated (DGX)?
- The return on invested capital (ROIC) for DGX stock is 8.43%.
- Is Quest Diagnostics Incorporated's return on invested capital (ROIC) high or low?
- The return on invested capital (ROIC) of 8.43% is 16% below its 5-year average of 10.04%, near the low end of its 5-year range (6.96%–15.26%).
- What is the TTM average return on invested capital (ROIC) for Quest Diagnostics Incorporated (DGX)?
- The TTM average return on invested capital (ROIC) for DGX stock is 7.70%.
- What is the 3Y average return on invested capital (ROIC) for Quest Diagnostics Incorporated (DGX)?
- The 3Y average return on invested capital (ROIC) for DGX stock is 8.24%.
- What is the 5Y average return on invested capital (ROIC) for Quest Diagnostics Incorporated (DGX)?
- The 5Y average return on invested capital (ROIC) for DGX stock is 10.04%.
- What is the 10Y average return on invested capital (ROIC) for Quest Diagnostics Incorporated (DGX)?
- The 10Y average return on invested capital (ROIC) for DGX stock is 9.57%.
- What is the 15Y average return on invested capital (ROIC) for Quest Diagnostics Incorporated (DGX)?
- The 15Y average return on invested capital (ROIC) for DGX stock is 9.09%.
- What is the 20Y average return on invested capital (ROIC) for Quest Diagnostics Incorporated (DGX)?
- The 20Y average return on invested capital (ROIC) for DGX stock is 9.69%.
DGX Return on Invested Capital (ROIC) History
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | 8.43% |
| 2024-12-31 | 6.96% |
| 2023-12-31 | 7.75% |
| 2022-12-31 | 9.83% |
| 2021-12-31 | 15.26% |
| 2020-12-31 | 12.02% |
| 2019-12-31 | 8.10% |
| 2018-12-31 | 8.78% |
| 2017-12-31 | 9.34% |
| 2016-12-31 | 8.47% |
| 2015-12-31 | 10.35% |
| 2014-12-31 | 7.82% |
| 2013-12-31 | 11.56% |
| 2012-12-31 | 9.08% |
| 2011-12-31 | 7.01% |
| 2010-12-31 | 10.83% |
| 2009-12-31 | 11.07% |
| 2008-12-31 | 10.56% |
| 2007-12-31 | 8.90% |
| 2006-12-31 | 14.15% |
| 2005-12-31 | 12.79% |
| 2004-12-31 | 15.24% |
| 2003-12-31 | 12.89% |
| 2002-12-31 | 12.96% |
| 2001-12-31 | 10.01% |
| 2000-12-31 | 7.63% |
| 1999-12-31 | -0.62% |
| 1998-12-31 | 4.27% |
| 1997-12-31 | 6.56% |
| 1996-12-31 | -47.72% |
Related Metrics
About Quest Diagnostics Incorporated
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- James E. Davis